Advancements in Breast Cancer Therapies

This chapter explores recent advancements in first-line therapies for VR-positive metastatic disease, delving into major clinical trials and their findings. It highlights the importance of individualized treatment strategies, discusses evolving therapeutic options like oral SERDs, and addresses the dynamics of treatment resistance. Additionally, the chapter examines the implications of combination therapies, challenges in patient screening, and the significance of progression-free survival rates in shaping clinical practices.